BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2886214)

  • 1. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
    Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
    Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.
    Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS
    Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the antiestrogen binding site is a histamine or histamine-like receptor.
    Brandes LJ; Macdonald LM; Bogdanovic RP
    Biochem Biophys Res Commun; 1985 Jan; 126(2):905-10. PubMed ID: 2858205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver.
    Brandes LJ; Davie JR; Paraskevas F; Sukhu B; Bogdanovic RP; LaBella FS
    Agents Actions Suppl; 1991; 33():325-42. PubMed ID: 2053513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
    Brandes LJ; Bogdanovic RP
    Biochem Biophys Res Commun; 1986 Jan; 134(2):601-8. PubMed ID: 3947341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding site.
    Brandes LJ; Bogdanovic RP; Cawker MD; Bose R
    Cancer Chemother Pharmacol; 1986; 18(1):21-3. PubMed ID: 3757154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
    Brandes LJ; Hogg GR
    J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diphenylmethane derivative specific for the antiestrogen binding site found in rat liver microsomes.
    Brandes LJ; Hermonat MW
    Biochem Biophys Res Commun; 1984 Sep; 123(2):724-8. PubMed ID: 6548377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites.
    Jones JA; Albright KD; Christen RD; Howell SB; McClay EF
    Cancer Res; 1997 Jul; 57(13):2657-60. PubMed ID: 9205073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiulcerogenic and antisecretory effects of a novel diphenylmethane derivative and antiestrogen binding site ligand.
    Glavin GB; Brandes LJ
    Can J Physiol Pharmacol; 1988 Sep; 66(9):1139-43. PubMed ID: 2905933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.
    Biswas R; Vonderhaar BK
    Cancer Res; 1989 Nov; 49(22):6295-9. PubMed ID: 2804977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
    Brandes LJ; LaBella FS; Warrington RC
    J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
    Xu FY; Queen G; Brandes L; Hatch GM
    Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA; Wiernas TK; Griffin BW; Davis TL
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.